Skip to content

Clinical trials

Scleroderma, Systemic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: United Kingdom Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20084
20092
20112
20122
20136
20143
20155
20163
20172
20192
20203
20213
20223
20234
20245
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated9
Unknown status9
Recruiting7
Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion3
Boehringer Ingelheim3
GlaxoSmithKline3
AstraZeneca2
Hoffmann-La Roche2
ISDIN2
Lakefront Biotherapeutics NV2
Royal Brompton & Harefield NHS Foundation Trust2
Sanofi2
Sheffield Hallam University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic55
Scleroderma, Diffuse13
Lung Diseases, Interstitial7
Raynaud Disease7
Autoimmune Diseases3
Hypertension, Pulmonary3
Ulcer3
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis2
Arthritis, Rheumatoid2
Immune System Diseases2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.